✦ LIBER ✦

1253 A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE USE OF PHOSPHODIESTERASE TYPE 5 INHIBITORS (PDE5-IS) FOR LOWER URINARY TRACT SYMPTOMS (LUTS) SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH)

✍ Scribed by Gacci, Mauro; Corona, Giovanni; Salvi, Matteo; Vignozzi, Linda; McVary, Kevin T.; Kaplan, Steven A.; Roehrborn, Claus G.; Serni, Sergio; Mirone, Vincenzo; Carini, Marco; Maggi, Mario

Book ID: 122532179
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 112 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.02.1571

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

644 Systematic review and meta-analysis

644 Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors (pde5-is) alone or in combination with alpha blockers for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

✍ M. Gacci; G. Corona; M. Salvi; L. Vignozzi; K.T. McVary; S.A. Kaplan; C.G. Roehr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 17 KB

Re: Phosphodiesterase-5 Inhibitors for L

Re: Phosphodiesterase-5 Inhibitors for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

✍ Kaplan, Steven A. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 64 KB

Phosphodiesterase 5 inhibitors for lower

Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review

✍ Humberto K. Laydner; Paulo Oliveira; Carlos Roberto A. Oliveira; Tafadzwa P. Mak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

Is there a rationale for the chronic use

Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?

✍ Thierry Roumeguère; K. Zouaoui Boudjeltia; Claude Hauzeur; Claude Schulman; Mich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

A Systematic Review and Meta-analysis on

A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

✍ Mauro Gacci; Giovanni Corona; Matteo Salvi; Linda Vignozzi; Kevin T. McVary; Ste 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Safety and feasibility of the prostatic

Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

✍ Henry H. Woo; Peter T. Chin; Thomas A. McNicholas; Harcharan S. Gill; Mark K. Pl 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB